Multi-Method Consumer Perception Investigations

The U.S. Food and Drug Administration (FDA) plans to issue a solicitation for "Multi-Method Consumer Perception Investigations," aiming to award a single Indefinite Delivery Indefinite Quantity (IDIQ) contract. This opportunity, expected to be released around March 20, 2019, will be a full and open competition with proposals due approximately by April 22, 2019. The services required under this contract are anticipated to be performed at the contractor’s site. Interested parties are invited to submit written questions by about March 27, 2019. The solicitation will include detailed attachments such as a draft work statement, labor category requirements, and an HHS subcontracting plan template. The solicitation, identified as FDA-RFP-19-1201023, falls under the NAICS code 541720, which pertains to research and development in the social sciences and humanities. The FDA has designated Richard Robinson as the Lead Contract Specialist and Matthew Bucher as the Contracting Officer for this procurement. The contract’s focus on consumer perception investigations indicates a multifaceted approach to understanding consumer responses, supporting the FDA’s regulatory and research objectives. The process aligns with FAR 5.201 regulations for publicizing contract opportunities.